Home > Insider Trading > Filing (0001181431-13-010686)

Filing Details

Accession Number:: 0001181431-13-010686
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-19 20:14:14
Reporting Period:: 2013-02-14

Filing Date:: 2013-02-19
Accepted Time:: 2013-02-19 20:14:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
927066	Davita Healthcare Partners Inc.	DVA	Services-Misc Health & Allied Services, Nec (8090)	510354549

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
315090	E Warren Buffett	3555 Farnam Street Omaha NE 68131		No	No	Yes	No
1067983	Berkshire Hathaway Inc	3555 Farnam Street Omaha NE 68131		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-14	29,180	$118.48	14,079,089	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-14	35,895	$119.19	14,114,984	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-14	777	$119.91	14,115,761	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-15	33,013	$116.77	14,148,774	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-15	65,718	$117.24	14,214,492	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-15	8,400	$118.46	14,222,892	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-19	28,407	$114.00	14,251,299	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-19	27,393	$114.76	14,278,692	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-19	54,244	$115.75	14,332,936	No	4	P	Indirect	See footnotes 11 and 12.
Common Stock	Acquisiton	2013-02-19	40,043	$116.59	14,372,979	No	4	P	Indirect	See footnotes 11 and 12.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.
No	4	P	Indirect	See footnotes 11 and 12.

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $117.88 to $118.87. The reporting person undertakes to provide to DaVita HealthCare Partners Inc. ("DaVita HCP"), any security holder of DaVita HCP, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $118.88 to $119.83.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $119.89 to $119.91.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $116.02 to $117.01.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $117.02 to $117.90.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $118.04 to $118.50.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $113.22 to $114.21.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $114.26 to $115.20.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $115.28 to $116.21.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $116.22 to $117.21.
6,000,000 of the total reported securities are owned by the following subsidiaries of Berkshire Hathaway Inc. ("Berkshire"): Government Employees Insurance Company ("Government Employees") (3,739,467) and GEICO Indemnity Company ("GEICO") (2,260,533). As Berkshire is in the chain of ownership of these subsidiaries, it may be deemed presently to both beneficially own and have a pecuniary interest in all shares of Common Stock presently owned by each subsidiary. Warren E. Buffett, as the controlling stockholder of Berkshire, may be deemed presently to beneficially own, but only to the extent he has a pecuniary interest in, the shares of Common Stock presently owned by each such subsidiary. Mr. Buffett disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
8,372,979 of the total reported securities are owned by the following pension plans of Berkshire's subsidiaries: Acme Brick Company Pension Trust (175,000), The Buffalo News Office Pension Plan (75,000), The Buffalo News Mechanical Pension Plan (25,000), The Buffalo News Drivers/Distributors Pension Plan (10,000), The Buffalo News Editorial Pension Plan (125,000), Dexter Pension Plan (100,000), Flightsafety International Inc. Retirement Income Plan (350,000), Fruit of the Loom Pension Trust (690,032), GEICO Corporation Pension Plan Trust (1,469,035), Johns Manville Corporation Master Pension Trust (1,305,100), Justin Brands, Inc. Union Pension Plan & Justin Brands, Inc. Pension & Trust (96,000), Scott Fetzer Collective Investment Trust (187,000), BNSF Master Retirement Trust (3,425,000) and Lubrizol Corp Master Trust Pension (340,812); each of Berkshire, Mr. Buffett and these pension plans disclaims beneficial ownership in such shares.